Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England.
about
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseSALSA: A Regulator of the Early Steps of Complement Activation on Mucosal SurfacesEpidemiology of intrafamilial inflammatory bowel disease throughout EuropeA multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistencyParticipants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trialMedication beliefs among patients with inflammatory bowel disease who report low quality of life: a qualitative study.Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studiesCharacteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.Inflammatory bowel diseases and the general practitioner's role in a region of Central Italy.Racial disparities in utilization of specialist care and medications in inflammatory bowel diseaseTools for primary care management of inflammatory bowel disease: do they exist?The fungal microbiota of de-novo paediatric inflammatory bowel disease.Epidemiologic Features of Inflammatory Bowel Disease in Guilan Province, North of Iran, During 2002-2012Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidenceCo-designing inflammatory bowel disease (Ibd) services in Scotland: findings from a nationwide surveyManagement of inflammatory bowel diseases in Eastern EuropeIs the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's diseaseDuration of treatment with 5-aminosalicylic acid compounds.The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation.Aseptic Abscesses and Inflammatory Bowel Disease: Two Cases and Review of Literature.Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer.The cost-effectiveness of infliximab in Crohn's disease.A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre.Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?Patients' perceptions of quality of care and follow-up in inflammatory bowel disease.Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.Lack of intestinal epithelial atg7 affects paneth cell granule formation but does not compromise immune homeostasis in the gut.Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational study.Ulcerative colitis in Madrid, Spain: current management.Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database.Conveying medication benefits to ulcerative colitis patients and effects on patient attitudes regarding thresholds for adherence.Beta-defensins and Crohn's disease: confusion from counting copies.Immunization status in children with inflammatory bowel disease.Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years.Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease.Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry
P2860
Q24645890-15FB330F-7827-41AC-BB2C-740B1C72CED2Q26751030-3FB580E5-819D-4024-BBC5-F8CFD8069C38Q26999295-0A6A32DD-7F97-4DB1-AAB1-922617884C63Q30430605-89A0AE50-C120-47B8-87E9-5F8390A82718Q30831712-37B95F67-8BFD-4BE9-ABEB-24E4EBC21CADQ33287234-82EC4476-64DA-402C-9CC5-EA126A803AB0Q33981316-F2C2B1D0-97BD-4E3F-ABFC-39C3BF840F43Q34035245-589D0C17-03F7-4347-8B55-49B287BA0852Q35010202-4EAF5E1E-7CE3-4C9B-AD4E-320693B875A5Q35026337-F687AA0D-6CCE-480B-B37A-626AD4AF6AC9Q35205595-3438A242-833F-42AA-8830-D2F91DF53336Q35472806-1A187C96-A1A6-41E2-A0C0-26265510DF59Q35529988-B5261A62-21AC-4135-A9ED-4408260FFA9CQ35603879-8ADE9EBC-C5C0-4683-BF7D-16EDEA762505Q35768888-C3934CA0-764E-45CF-B74E-074D46EF1C98Q36071463-C5DDD7EB-C09D-4B30-94D3-9A52421370CDQ36441778-D781F465-402A-462F-81B1-27469D2C19DAQ36470492-4A69DE27-D083-444E-985B-CF8905B4AD82Q36852315-0D17ADDE-9916-495D-9A27-9A6DDCB37AA7Q36914360-7401D971-E74D-4D47-BD1A-1E23B674CE5BQ37426522-9BC3A3A0-2768-46BE-8405-E739456A0ADCQ37652551-04DBD40F-F903-4814-9506-650D941828D5Q37764367-F22F75AE-7A09-4257-9381-2B4AFE3F0086Q38241338-5C1DBDA2-2B9E-43EA-81E6-1D0B7686DE35Q38609204-F155182F-1E94-4017-8C38-492FAF42C84EQ38915531-1C5A9C21-154D-4EA3-AF42-0FE27C8F052AQ40243918-C3DE796C-B6EE-4D2C-A28F-D629E2857AFAQ40446101-F5F0A540-300C-4D7A-8591-A09EBCF536CEQ40628192-18791435-59D3-4750-8821-B52ABEEB2FC5Q42293551-B3DFE98C-FC70-4276-8B0A-1F51F4503A28Q43148523-9D03AA53-20F7-46B0-9D3A-EF1A06CCC129Q43606787-B586E95B-FAAC-4781-BF4B-448C14F112A7Q43764999-2017CDFC-A10E-4BCD-B876-AC32E0A48F51Q44034130-62D5344B-2BA0-432B-A8C5-AFB2A4680727Q44831519-C586C2FC-C646-4C11-860B-61797A9D5040Q46747559-A9C93C8A-F6F9-4F91-ABCF-337EDF7D5249Q47901863-F578257B-F3EC-49EE-82A1-1363BFA60178Q57113895-0EC07F0B-2EC9-483A-8EC4-E06AF623EF4D
P2860
Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Prevalence and management of i ...... al study from central England.
@en
Prevalence and management of i ...... al study from central England.
@nl
type
label
Prevalence and management of i ...... al study from central England.
@en
Prevalence and management of i ...... al study from central England.
@nl
prefLabel
Prevalence and management of i ...... al study from central England.
@en
Prevalence and management of i ...... al study from central England.
@nl
P2093
P1476
Prevalence and management of i ...... al study from central England.
@en
P2093
John F Mayberry
Margaret A Stone
Richard Baker
P304
P356
10.1097/00042737-200312000-00004
P577
2003-12-01T00:00:00Z